Intestinal microbiota and colorectal cancer: a new aspect of research

被引:2
|
作者
Koliarakis, Ioannis [1 ]
Psaroulaki, Anna [2 ]
Nikolouzakis, Taxiarchis Konstantinos [1 ]
Kokkinakis, Manolis [3 ]
Sgantzos, Markos N. [4 ]
Goulielmos, George [5 ]
Androutsopoulos, Vasilis P. [3 ]
Tsatsakis, Aristides [3 ]
Tsiaoussis, John [1 ]
机构
[1] Univ Crete, Lab Anat Histol Embryol, Med Sch, Iraklion 71110, Greece
[2] Univ Crete, Dept Clin Microbiol & Microbial Pathogenesis, Med Sch, Iraklion 71110, Greece
[3] Univ Crete, Lab Forens Sci & Toxicol, Med Sch, Iraklion 71409, Greece
[4] Univ Thessaly, Dept Anat, Fac Med, Larisa 41500, Greece
[5] Univ Crete, Sect Mol Pathol & Human Genet, Dept Internal Med, Med Sch, Iraklion 71003, Greece
来源
JOURNAL OF BUON | 2018年 / 23卷 / 05期
关键词
bowel preparation; chemotherapy; colorectal cancer; immunotherapy; intestinal microbiota; pathogenesis; ENTEROTOXIGENIC BACTEROIDES-FRAGILIS; INFLAMMATORY-BOWEL-DISEASE; TOLL-LIKE RECEPTORS; CHAIN FATTY-ACIDS; GUT MICROBIOTA; BETA-GLUCURONIDASE; COLON-CANCER; GASTROINTESTINAL MICROFLORA; CHECKPOINT-BLOCKADE; MOLECULAR-GENETICS;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Colon holds a complex microbial community, which is crucial for maintaining homeostasis and regulating metabolic functions, supporting the intestinal barrier and controlling immune responses. Previous studies have supported a link between intestinal microbiota and colorectal cancer (CRC). Based on these findings, the present review analyzed the numerous interactions that occur between microbiota and CRC, starting from the role of intestinal microbiota in colonic homoeostasis. Intestinal microbiota is a cause of CRC and involves various mechanisms such as chronic inflammation, the production of genotoxins causing DNA impairment and/or the biosynthesis of toxic compounds. Moreover, basic metabolic factors such as short-chain fatty acids (SCFAs) and bile acids are included in CRC pathogenesis. Different pathogenic pathways have been reported among different CRC regions (proximal or distal). Variations in the microbial populations are reported between the CRC from these colonic sites, possibly reflecting the bacterial dysbiosis and biofilm distribution. Bowel preparation is essential prior to colonoscopy and surgery; there is, however, minor consensus on the effects of this procedure on intestinal microbiota, notably with regard to the long-term outcomes. With regard to the therapeutic strategy in CRC, the intestinal microbiota is further involved in the modulation of the host response to chemotherapeutic agents (5-fluorouracil and irinotecan) by the interference with drug efficacy and by adverse effects and associated toxicity. In addition, the newly emerged research on CRC immunotherapy reveals an important interplay between intestinal microbiota and the immune system, which includes the possibility of targeting microbiota for the enhancement of anticancer treatment. Additional studies will further clarify the interaction between microbiota and CRC, resulting in the development of alternative therapeutic strategies by manipulating microbiota composition.
引用
收藏
页码:1216 / 1234
页数:19
相关论文
共 50 条
  • [31] Natural polysaccharides regulate intestinal microbiota for inhibiting colorectal cancer
    Liu, Lili
    Li, Yinan
    Zheng, Xiaoting
    Huang, Rong
    Huang, Xiaoli
    Zhao, Yonghui
    Liu, Wenjing
    Lei, Yanli
    Li, Qiu
    Zhong, Zhangfeng
    Zhao, Ziyun
    HELIYON, 2024, 10 (10)
  • [32] Analysis of the Intestinal Lumen Microbiota in an Animal Model of Colorectal Cancer
    Zhu, Qingchao
    Jin, Zhiming
    Wu, Wen
    Gao, Renyuan
    Guo, Bomin
    Gao, Zhiguang
    Yang, Yongzhi
    Qin, Huanlong
    PLOS ONE, 2014, 9 (03):
  • [33] Intestinal Microbiota Influences DNA Methylome and Susceptibility to Colorectal Cancer
    Zouggar, Aicha
    Haebe, Joshua R.
    Benoit, Yannick D.
    GENES, 2020, 11 (07)
  • [34] Role of Intestinal Microbiota in the Pathogenesis of Colorectal Cancer: A Narrative Review
    Menon, Sharanya
    Kadhit, Kanishk
    Shukla, Samarth
    Acharya, Sourya
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2024, -18 (01) : OE1 - OE5
  • [35] Assessment of oncogenic role of intestinal microbiota in colorectal cancer patients
    Tha’ir Abid D’asheesh
    Bashdar Mahmud Hussen
    Ali H. Al-Marzoqi
    Abdolmajid Ghasemian
    Journal of Gastrointestinal Cancer, 2021, 52 : 1016 - 1021
  • [36] Effects of fecal microbiota transplantation combined with selenium on intestinal microbiota in mice with colorectal cancer
    Su, Yintong
    Fan, Xingxing
    Cai, Xiaohua
    Ning, Jiayu
    Shen, Mei
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2024, 733
  • [37] Intestinal microbiota: a new force in cancer immunotherapy
    Zhujiang Dai
    Jingqiu Zhang
    Qi Wu
    Huiwen Fang
    Chunfeng Shi
    Zhen Li
    Chaobiao Lin
    Dong Tang
    Daorong Wang
    Cell Communication and Signaling, 18
  • [38] Intestinal microbiota: a new force in cancer immunotherapy
    Dai, Zhujiang
    Zhang, Jingqiu
    Wu, Qi
    Fang, Huiwen
    Shi, Chunfeng
    Li, Zhen
    Lin, Chaobiao
    Tang, Dong
    Wang, Daorong
    CELL COMMUNICATION AND SIGNALING, 2020, 18 (01)
  • [39] The Microbiota: A New Player in the Etiology of Colorectal Cancer
    Levy, Maayan
    Thaiss, Christoph A.
    Elinav, Eran
    CURRENT COLORECTAL CANCER REPORTS, 2014, 10 (01) : 1 - 8
  • [40] New Insights on the Role of the Microbiota in the colorectal Cancer
    Zeissig, Sebastian
    Hampe, Jochen
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2016, 54 (05): : 406 - 408